Just incase its not been posted as of yet.
Today in the mail on line
More than a quarter of a million packs of blood pressure drugs have been recalled in the UK.
Government agency the Medicines and Healthcare products Regulatory Agency today issued a warning about losartan pills made by the company Accord.
Some of the drugs have already been on the market for two years, after first going to market as long ago as February 2017.
It is the latest in a line of drug recalls of sartan-type medications, which may have been exposed to cancer-causing chemicals in factories in China and India.
Today's is the fifth recall by the MHRA – patients are urged to not stop taking their medication unless told to by their doctor or pharmacist.
Packs of 28 of losartan pills made by the company Accord have been recalled by the UK Government amid concerns they might contain a cancer-causing chemical
The recall affects Losartan Potassium Film-coated tablets, both 50mg and 100mg, which come in packs of 28.
The expiry dates of the packets are in June 2019, November 2019 and August 2020.
A total of 264,797 packets are included in the batches, amounting to a possible total of 7.4million tablets.
Other similar drugs including irbesartan and valsartan have been recalled over the past year amid concerns about dangerous chemicals getting into them.
WHICH DRUGS ARE INCLUDED IN TODAY'S RECALL?
PRODUCT NAME
BATCH NUMBER
EXPIRY DATE
PACK SIZE
PL NUMBER
DATE OF FIRST DISTRIBUTION
Losartan Potassium 50mg Film-coated Tablets
PT04882
Nov-19
1 x 28
20075/0022
28-Mar-18
Losartan Potassium 100mg Film-coated Tablets
PT02738
Jun-19
1 x 28
20075/0023
27-Feb-17
Losartan Potassium 100mg Film-coated Tablets
GX0135
Aug-20
1 x 28
20075/0023
07-Feb-19
TIMELINE OF COMMON BLOOD PRESSURE DRUGS' RECENT RECALLS
2012 - The blood-pressure medication valsartan is thought to have been contaminated with the cancer-causing, rocket-fuel chemical NDMA as far back as 2012.
European regulators warned last year the medication's main manufacturer in China - Zhejiang Huahai Pharmaceutical - changed its manufacturing process seven years ago, which may have been to blame.
July 5, 2018 - The UK recalled the drug over growing concerns and many EU authorities then followed suit.
The European Medicines Agency said it was working to establish how long, and at what levels, patients might have been exposed to NDMA.
July 17 - The US Food and Drug Administration ordered a ban on valsartan's prescription.
July 30 - China's National Health and Family Planning Commission said the drug must not be used for diagnosis or treatment.
January 3, 2019 - The Medicines and Healthcare products Regulatory Agency (MHRA) recalled thousands of medications containing the blood-pressure drug irbesartan over NDEA fears.
The government-run body issued an alert over four batches of the medication and pulled the products - made by Actavis, now known as Accord - as a 'precautionary measure'.
January 23, 2019 - Prinston Pharmaceutical Inc, a medicine company in the US, announced it was voluntarily recalling irbesartan and irbesartan HCTZ after finding higher levels of NDEA in them than the Food and Drug Administration permits.
January 24, 2019 - The UK's MHRA issued a further recall of three more batches of irbesartan, this time concerning 150mg and 300mg film-coated tablets supplied by Macleods Pharma UK.
March 12, 2019 - The Food and Drug Administration in the US rushed to try and approve new generic versions of valsartan amid a shortage caused by contamination problems leading to recalls.
March 21, 2019 - MHRA recalls three batches of losartan, a blood pressure medication, amid concerns it could be contaminated by a chemical known as NMBA, which has only surfaced this month in a factory in India.
This recall shows we are continuing to investigate potential contamination of sartan containing medicines.
'There is no evidence at present that medicines containing NDMA, NDEA or NMBA have caused any harm to patients and this recall is a precautionary measure.
'Because of the risk associated with suddenly stopping high blood pressure medication, continue to take your medicines as prescribed by your doctor.
'Please speak to your doctor or pharmacist if you have any concerns about your medicine.'